Associate Professor
Diabetes Research Institute and University of Miami, USA

---

Dr. Tomei is the Miami Engineering Career Development Associate Professor of Biomedical Engineering, Microbiology and Immunology, and Surgery, and the director of the Islet Immunoengineering Laboratory at the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine. She holds a MS in Materials Engineering from the Politecnico of Milan (Italy) and a PhD in Bioengineering and Biotechnology from the Ecole Polytechnique Fédérale de Lausanne (EPFL, Switzerland).

Dr. Tomei is applying her unique background in bioengineering and immunology to develop novel immunoengineering platforms to prevent rejection after islet transplantation and to promote antigen-specific tolerance for a cure of type-1 diabetes.

Dr. Tomei has secured and successfully administered grants from the NIH, JDRF, Johnson & Johnson, Semma Therapeutics and Sernova Corp. She serves as a standing member for the NIH BMBI study section and as a member of the CIRM grant working group. She is a CTRMS councilor and member of the IPITA education committee. She was awarded the Marc S. Goodman Prize to an Outstanding Young Scientist, the JDRF career development award, the Eliahu I. Jury Early Career Research Award, the Johnson A. Edosomwan Researcher of the Year Award, the CMBE Young Innovator, and the Alexander Orr Excellence in Teaching Award.

Director of Center for Regenerative Biotherapeutics at Mayo Clinic;
Associate Professor of Regenerative Medicine
Jacksonville, FL, USA

---

Julie Allickson, Ph.D., is the Michael S. and Mary Sue Shannon director of Mayo Clinic's Center for Regenerative Biotherapeutics and the Otto Bremer Trust director, Biomanufacturing and Product Development, Center for Regenerative Biotherapeutics and Associate Professor of Regenerative Medicine. Dr. Allickson is leading the next phase of development of the Center for Regenerative Biotherapeutics as it delivers on innovations that Cure, Connect and Transform patient care in alignment with Mayo Clinic's 2030 vision. She directs the enterprise-wide biomanufacturing strategy that aspires to introduce new regenerative therapeutics into the practice and establish Mayo Clinic as a category of one in regenerative medicine for rare and complex conditions. Dr. Allickson provides strategic leadership for all center activities and operations across the Mayo Clinic Enterprise. The Center for Regenerative Biotherapeutics has over 25 clinical trials in cell & gene therapy underway. With more than 25 years of experience in clinical translation of cellular therapies and regenerative medicine products, Dr. Allickson has expertise in business management, regulatory affairs, strategic planning, project management and team building. She has been in industry and academic healthcare facilities. She has served as an executive officer of a publicly traded company that builds services for cellular banking, including licensure of technology with international affiliates. Mayo Clinic, Center for Regenerative Biotherapeutics across the enterprise including Minnesota, Arizona, and Florida. We are building a team of industry experienced leaders to frame a successful structure for Biomanufacturing including cellular therapies, gene and viral therapies, and tissue engineering and bioprinting technology.

Professor & Chair, Department of Otolaryngology – Head & Neck Surgery
Director, Head & Neck Regenerative Medicine & Transplantation Program
Associate Director, Center for Regenerative Biotherapeutics
Mayo Clinic - Arizona, Phoenix, AZ, USA

---

Dr. Lott received his M.D. degree at the University of Iowa Carver College of Medicine and completed a residency in Otorhinolaryngology/Head & Neck Surgery at the Cleveland Clinic Head & Neck Institute. He received further fellowship training in Laryngeal Surgery and Professional Voice at Harvard Medical School/Massachusetts General Hospital. In addition to his thriving surgical practice, he is actively involved in research, education and community outreach at Mayo Clinic – Arizona.